⌘K

11:15:03·72d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Voyager Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.

VYGR· Voyager Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

VYGR
Voyager Therapeutics Inc.
Health Care

Recent analyst ratings

Jan 10UpdateCantor Fitzgerald-
Dec 2UpdateCitigroup$12.00
Nov 29UpdateWedbush$11.00
Oct 16UpdateLeerink Partners$15.00
Mar 26UpdateGuggenheim$22.00
Mar 19UpdateH.C. Wainwright$30.00

Related

SEC2d
SEC Form DEFA14A filed by Voyager Therapeutics Inc.
SEC2d
SEC Form DEF 14A filed by Voyager Therapeutics Inc.
SEC9d
Voyager Therapeutics Inc. filed SEC Form 8-K: Leadership Update
SEC20d
SEC Form PRE 14A filed by Voyager Therapeutics Inc.
INSIDER27d
SEC Form 4 filed by Sandrock Alfred
INSIDER27d
SEC Form 4 filed by Shiferman Gregory L.
SEC28d
SEC Form 144 filed by Voyager Therapeutics Inc.
SEC34d
Amendment: SEC Form SCHEDULE 13G/A filed by Voyager Therapeutics Inc.